The HOXB7 protein renders breast cancer cells resistant to tamoxifen through activation of the EGFR pathway
10.1073/pnas.1018859108
Saved in:
Main Authors: | Jin, K., Kong, X., Shah, T., Penet, M.-F., Wildes, F., Sgroi, D.C., Ma, X.-J., Huang, Y., Kallioniemi, A., Landberg, G., Bieche, I., Wu, X., Lobie, P.E., Davidson, N.E., Bhujwalla, Z.M., Zhu, T., Sukumar, S. |
---|---|
Other Authors: | PHARMACOLOGY |
Format: | Article |
Published: |
2014
|
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/108572 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
A calcineurin–Hoxb13 axis regulates growth mode of mammalian cardiomyocytes
by: Nguyen, NUN, et al.
Published: (2021) -
Synthesis and in vitro anti-cancer evaluation of tamoxifen-loaded magnetite/PLLA composite nanoparticles
by: Hu, F.X., et al.
Published: (2014) -
Tamoxifen-induced eccrine squamous syringometaplasia
by: Teoh, D.C.-W., et al.
Published: (2014) -
Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk
by: Liu, J., et al.
Published: (2021) -
Hypomethylation associated enhanced transcription of trefoil factor-3 mediates tamoxifen-stimulated oncogenicity of ER+ endometrial carcinoma cells
by: Pandey, V, et al.
Published: (2020)